Kieron M. Dunleavy is an expert in the field of Oncology. Kieron Dunleavy is also published. He has 17 publications published. The lastest publication: "Targeted PI3K inhibition by the small molecule idelalisib as a novel therapy in indolent non-Hodgkin lymphoma.'
![]() |
Dr. Richard Piekarz, MD
![]() ![]() |
![]() |
Dr. Norman Coleman, MD
![]() ![]() |
![]() |
Dr. Suparna B. Wedam, MD
![]() |
![]() |
Dr. Dickran G. Kazandjian, MD |
![]() |
Dr. Christopher S. Hourigan, MD
![]() ![]() |
![]() |
Dr. James H. Doroshow, MD
![]() ![]() |
![]() |
Dr. Wyndham H. Wilson, MD |
![]() |
Dr. Lee J. Helman, MD
![]() ![]() |
![]() |
Dr. Robert J. Lechleider, MD
![]() ![]() |
![]() |
Dr. C N. Coleman, MD
![]() ![]() |
![]() |
Dr. Ralph V. Boccia, MD
![]() ![]() |